{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T14:11:22Z","timestamp":1760278282486,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004240","name":"Academy of Sciences of the Czech Republic","doi-asserted-by":"crossref","award":["P304\/10\/1274"],"award-info":[{"award-number":["P304\/10\/1274"]}],"id":[{"id":"10.13039\/501100004240","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.eplepsyres.2013.06.001","type":"journal-article","created":{"date-parts":[[2013,6,28]],"date-time":"2013-06-28T17:30:36Z","timestamp":1372440636000},"page":"64-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Derivatives of valproic acid are active against pentetrazol-induced seizures in immature rats"],"prefix":"10.1016","volume":"106","author":[{"given":"Pavel","family":"Mare\u0161","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hana","family":"Kubov\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nama","family":"Hen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boris","family":"Yagen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meir","family":"Bialer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eplepsyres.2013.06.001_bib0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0149-7634(03)00005-8","article-title":"Trajectories of brain development: point of vulnerability or window of opportunity?","volume":"27","author":"Andersen","year":"2003","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.eplepsyres.2013.06.001_bib0010","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nrd2997","article-title":"Key factors in the discovery and development of new antiepileptic drugs (AEDs)","volume":"9","author":"Bialer","year":"2010","journal-title":"Nature Rev. Drug Discov."},{"key":"10.1016\/j.eplepsyres.2013.06.001_bib0015","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.nurt.2006.11.007","article-title":"Valproic acid \u2013 second generation","volume":"4","author":"Bialer","year":"2007","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.eplepsyres.2013.06.001_bib0020","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.yebeh.2004.08.021","article-title":"Correlation analysis between anticonvulsant \u2013 ED50 values of antiepileptic drugs in mice and rats and their therapeutic doses and plasma levels","volume":"5","author":"Bialer","year":"2004","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.eplepsyres.2013.06.001_bib0025","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/0014-4886(86)90174-3","article-title":"Modification of electroshock and pentylenetetrazol seizure patterns in rats after precollicular transections","volume":"93","author":"Browning","year":"1986","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.eplepsyres.2013.06.001_bib0030","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1212\/WNL.46.2.465","article-title":"Valproic acid hepatic fatalities. III. US experience since 1986","volume":"46","author":"Bryant","year":"1996","journal-title":"Neurology"},{"year":"1952","series-title":"Probit Analysis","key":"10.1016\/j.eplepsyres.2013.06.001_bib0035"},{"key":"10.1016\/j.eplepsyres.2013.06.001_bib0040","series-title":"Antiepileptic Drugs","first-page":"837","article-title":"Valproic acid. Adverse effects","author":"Genton","year":"2002"},{"key":"10.1016\/j.eplepsyres.2013.06.001_bib0045","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/sj.bjp.0705076","article-title":"Characterization of the anticonvulsant activity and enantioselective pharmacokinetics of the chiral valproylamido propylisopropyl acetamide in rodents","volume":"138","author":"Isoherranen","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2013.06.001_bib0050","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1023\/A:1025069519218","article-title":"Pharmacokinetic\u2013pharmacodynamic relationships of (2S,3S)-valnoctamide and its stereoisomer (2R,3S)-valnoctamide in rodent models of epilepsy","volume":"20","author":"Isoherranen","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/j.eplepsyres.2013.06.001_bib0055","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.neuropharm.2010.03.004","article-title":"Evaluation of the antiallodynic, teratogenic and pharmacokinetic profile of stereoisomers of valnoctamide, an amide derivative of a chiral isomer of valproic acid","volume":"58","author":"Kaufmann","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.eplepsyres.2013.06.001_bib0060","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1023\/A:1007559208599","article-title":"In vivo study of the effect of valpromide and valnoctamide in the pilocarpine rat model of focal epilepsy","volume":"17","author":"Lindekens","year":"2000","journal-title":"Pharm. Res."},{"key":"10.1016\/j.eplepsyres.2013.06.001_bib0065","first-page":"PL51","article-title":"Ontogeny of ethosuximide action against two seizure models in rats is different","volume":"63","author":"Mare\u0161","year":"1998","journal-title":"Life Sci. (Pharmacol. Lett.)"},{"key":"10.1016\/j.eplepsyres.2013.06.001_bib0070","series-title":"Generalized Seizures: From Clinical Phenomenology to Underlying Systems and Networks","first-page":"70","article-title":"Generalized seizures in rodents \u2013 only two patterns?","author":"Mare\u0161","year":"2006"},{"key":"10.1016\/j.eplepsyres.2013.06.001_bib0075","first-page":"1072","article-title":"Quantitative and qualitative changes of action of antiepileptic drugs in developing experimental animals","volume":"vol. 2","author":"Mare\u0161","year":"2009"},{"key":"10.1016\/j.eplepsyres.2013.06.001_bib0080","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.eplepsyres.2012.01.007","article-title":"Anticonvulsant action of GABAB receptor positive modulator CGP7930 in immature rats","volume":"100","author":"Mare\u0161","year":"2012","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2013.06.001_bib0085","first-page":"113","article-title":"Effect of antiepileptic drugs on metrazol convulsions during ontogenesis in the rat","volume":"30","author":"Mare\u0161","year":"1981","journal-title":"Physiol. Bohemoslov."},{"key":"10.1016\/j.eplepsyres.2013.06.001_bib0090","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/j.1460-9568.2009.06648.x","article-title":"Age matters","volume":"29","author":"McCutcheon","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.eplepsyres.2013.06.001_bib0095","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/0920-1211(87)90006-4","article-title":"Flunarizine influences metrazol-induced seizures in developing rats","volume":"1","author":"Pohl","year":"1987","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.eplepsyres.2013.06.001_bib0100","first-page":"7","article-title":"Pharmacological models of generalized absence seizures in rodents","volume":"35","author":"Snead","year":"1992","journal-title":"J. Neural. Transm. Suppl."},{"key":"10.1016\/j.eplepsyres.2013.06.001_bib0105","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/BF00169017","article-title":"Pentylenetetrazol-induced seizures in rats: an ontogenetic study","volume":"346","author":"Vel\u00ed\u0161ek","year":"1992","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.eplepsyres.2013.06.001_bib0110","series-title":"Antiepileptic Drugs","first-page":"36","article-title":"Discovery and preclinical development of antiepileptic drugs","author":"White","year":"2002"},{"key":"10.1016\/j.eplepsyres.2013.06.001_bib0115","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1212\/01.WNL.0000154516.43630.C5","article-title":"Antiepileptic drug pregnancy registry, increased rate of major malformations in offspring exposed to valproate during pregnancy","volume":"64","author":"Wyszynski","year":"2005","journal-title":"Neurology"}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121113001514?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121113001514?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:29:51Z","timestamp":1760275791000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121113001514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":23,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0920121113001514"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2013.06.001","relation":{},"ISSN":["0920-1211"],"issn-type":[{"type":"print","value":"0920-1211"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Derivatives of valproic acid are active against pentetrazol-induced seizures in immature rats","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2013.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}